Science Explorer Back to mapMap
Discussion
Researcher · Noxxon Pharma (Germany) · Germany

Diana Beyer

Diana Beyer publishes mostly in Oncology, Immunology and Allergy and Biotechnology, on topics such as Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies and Cancer Research and Treatments.

OpenAlex
World rank
#2,896,968
of 7,710,434 ranked researchers
Rank in Germany
#143,960
of 364,343
Works
15
Citations
469
Citations per work
31.3
h-index
8
i10-index 5Top 72% in Oncology
Diana Beyer

What does Diana Beyer research?

Diana Beyer's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (7%), Immunology and Microbiology (7%).

Health Sciences: 7 works · 44.2% of their workMedicine: 7 works · 44.2% of their workOncology: 5 works · 30.2% of their workHepatology: 1 works · 7.0% of their workImmunology and Allergy: 1 works · 7.0% of their workEverything else: 6 works · 37.1% of their workLife Sciences: 2 works · 14.0% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 7.0% of their workBiotechnology: 1 works · 7.0% of their workImmunology and Microbiology: 1 works · 7.0% of their workImmunology: 1 works · 7.0% of their workSocial Sciences: 1 works · 4.7% of their workBusiness, Management and Accounting: 1 works · 4.7% of their workOrganizational Behavior and Human Resource Management: 1 works · 4.7% of their workTHEIR WORKDiana Beyer15works
Life Sciences14%Health Sciences44%Social Sciences5%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine744.2%
  2. Everything else637.1%
    1. Biochemistry, Genetics and Molecular Biology17.0%
    2. Immunology and Microbiology17.0%
    1. Business, Management and Accounting14.7%
  1. 1Oncology30% of their works
  2. 2Immunology and Allergy7% of their works
  3. 3Biotechnology7% of their works
  4. 4Immunology7% of their works
  5. 5Hepatology7% of their works
  6. 6Organizational Behavior and Human Resource Management5% of their works

Research topics

Which keywords describe Diana Beyer's research?

The keywords of their largest research topics: Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Cetuximab, KRAS Mutations, Bacterial Therapy, Cell Adhesion and Hepatocellular Carcinoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Tumor Microenvironment82 topics
  2. Immune Checkpoint Blockade71 topic
  3. PD-1 and PD-L171 topic
  4. Cetuximab51 topic
  5. KRAS Mutations51 topic
  6. Bacterial Therapy31 topic
  7. Cell Adhesion31 topic
  8. Hepatocellular Carcinoma31 topic
  9. Integrins31 topic
  10. Liver Cancer31 topic
  11. Tumor Targeting31 topic
  12. Cyclotides11 topic
  13. Drug Discovery11 topic
  14. HIF-111 topic
  15. Peptide Synthesis11 topic
  16. Sortase11 topic
  17. Warburg Effect11 topic

Where does Diana Beyer work?

Diana Beyer's main affiliation in the publication record is Noxxon Pharma (Germany), Germany.

How many publications and citations does Diana Beyer have?

OpenAlex counts 15 works and 469 citations for Diana Beyer, an h-index of 8, ranking #2,896,968 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Diana Beyer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.